Skip to content

Study reveals potential challenges for scaling up of HCV therapy in UK

Women living with HIV in the UK continue to have poorer treatment outcomes

How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations

Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound

Priorities for HIV care: the perspectives of healthcare providers and patients

HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial

Carey Hwang, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

START sub-studies show no differences in lung or neurocognitive function with early or later treatment

Ken Kunisaki, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

START sub-study shows more bone loss with earlier HIV treatment

Jennifer Hoy, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Risk of heart attack rises with length of HIV infection, regardless of age

Risk of heart attack rises with length of HIV infection, regardless of age